Dennis Phillip Andrew
- SEC CIK
- 0002089237
Latest role at each company
- NBP NovaBridge BiosciencesChief Medical Officeras of Sep 21, 2026
Trades
Every Form 4 that lists Dennis Phillip Andrew as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| NBPNovaBridge Biosciences | Sep 21, 20264:05 PM ET | Sep 18, 2026 | Dennis Phillip AndrewChief Medical Officer | SSaleOrdinary Shares | −8.21K | $0.71 | −$5.83K | 173.43K | −4.5% | SEC |
| NBPNovaBridge Biosciences | Jun 22, 2026 | Jun 18, 2026 | Dennis Phillip AndrewChief Medical Officer | SSaleOrdinary Shares | −8.49K | $0.66 | −$5.61K | 157.94K | −5.1% | SEC |